oVRcome
oVRcome is a New Zealand-based virtual reality exposure therapy company delivering smartphone-based VR treatment for phobias and anxiety disorders. It serves clinicians through a web portal and individuals via direct subscriptions, supported by a 1,000+ clip content library and generative AI personalization.
- Company typePrivate
- Founded2020
- HeadquartersChristchurch, New Zealand
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What oVRcome does
oVRcome is a New Zealand-based virtual reality exposure therapy (VRET) company founded in 2020 that delivers smartphone-based VR content for treating anxiety disorders and phobias. Its core platform combines an individual-facing mobile application with a web-based Clinician Portal that allows licensed mental health practitioners to direct live exposure sessions, build hierarchies, assign homework, and monitor client engagement analytics. The platform is built on a library of 1,000+ ultra HD 5.7K real-life 360° VR experiences covering diverse fear scenarios, supported by proprietary generative AI capabilities that produce personalized exposure videos for individual patients within 3-5 days under clinician safety review. Compliance posture includes HIPAA, GDPR, CSA STAR Level 1, UK DSPT 2025-26, and an in-progress APA Labs Digital Badge.
The company operates a dual-track business model: direct-to-consumer subscriptions through its website, Apple App Store, and Google Play Store for self-guided therapy, alongside a B2B Clinician Portal offered in Free (up to 2 active clients) and Professional (unlimited clients) tiers with a Pay What You Want pricing experiment running through 2025. Revenue streams include individual subscriptions, clinician subscriptions, hardware sales of smartphone-compatible VR headsets, and gift subscriptions. The company also offers Bespoke VR Solutions for institutional clients, a Health Plans product targeting insurance reimbursement pathways, and a Research Projects program enabling academic collaborations, with content community-building through a Freelance Filmer royalty program.
oVRcome reports 1,800+ organizations, 2,000+ clinicians, and 150,000+ VR exposure sessions delivered across 89 countries. The company has validated its approach through clinical trials with the University of Otago and a generative AI pilot with the University of Canterbury, and is pursuing APA Labs validation in partnership with APA Services, Inc. The primary platform runs on smartphone-compatible VR headsets rather than standalone devices, though a 2025 University of Canterbury research initiative extends the technology to Meta Quest Pro with Samsung Galaxy wearable physiological data capture. The company is actively raising capital and is led by founder Adam Hutchinson, with Elizabeth Jennings heading strategic partnerships.
oVRcome firmographics
Firmographics- Name
- oVRcome
- Legal name
- oVRcome Limited
- Website
- https://ovrcome.io
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- oVRcome is a New Zealand-based virtual reality exposure therapy company delivering smartphone-based VR treatment for phobias and anxiety disorders. It serves clinicians through a web portal and individuals via direct subscriptions, supported by a 1,000+ clip content library and generative AI personalization.
- Ownership category
- akta.pro rank
oVRcome industry classification
Industry- Product category
- Digital Mental Health / Virtual Reality Exposure Therapy
- NAICS
- Offices of Physicians, Mental Health Specialists (621112)
- SIC
- Services-Computer Programming Services (7371)
- akta.pro primary industry
- Immersive/Interactive Animation (AR/VR/Real-Time) (MPAHACAN)
- akta.pro secondary industries
- VR-Based Skills Training Simulations (Soft Skills, Customer Service, Leadership) (EDAFAJAA), VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics) (MPAFAGAG)
Keywords
Where oVRcome is headquartered
LocationHeadquarters
- HQ city
- Christchurch
- HQ country
- New Zealand
- HQ region
- Oceania
Offices1 record
Markets served
oVRcome business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Individual Subscriptions: Monthly and annual subscription fees for individual consumers accessing VR exposure therapy programs for phobias and anxiety. Subscriptions provide full access to oVRcome programs and related content with pricing in USD.
- Clinician Portal Subscriptions: Free tier with up to 2 active clients; Professional tier with unlimited clients and premium support. Clinicians can subscribe for paid access to the platform to use with their patients.
- Hardware Sales (VR Headsets): oVRcome VR headsets available for purchase as part of subscriptions. Free with annual subscription when purchased via web; additional cost with monthly subscription. Headsets ship from US and New Zealand with international delivery available.
- Gift Subscriptions: Pre-paid gift memberships available for purchase as one-time upfront payments, sent to recipients on specified dates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Pay What You Want for Clinicians |
| Freemium | Monthly | Free Clinician Version |
| Subscription | Monthly | Professional Clinician Version |
| Subscription | Annual | Individual Annual Subscription |
| Subscription | Monthly | Individual Monthly Subscription |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
oVRcome product offering
Product offeringCore offering
oVRcome provides a virtual reality exposure therapy (VRET) platform that combines a smartphone-based VR app for individuals with a web-based Clinician Portal for licensed mental health professionals. The platform delivers clinician-directed and self-guided immersive 360° VR experiences for treating phobias, social anxiety, and related anxiety disorders, supported by a library of 1,000+ ultra HD 5.7K clips and AI-generated personalized exposure content.
Product overview
oVRcome is a Virtual Reality Exposure Therapy (VRET) platform that combines a smartphone-based VR application with a Clinician Portal for mental health professionals. The core offering consists of the oVRcome App (for individuals) and the oVRcome Clinician Portal (available in Free and Professional tiers), which together provide a complete VR-based anxiety treatment ecosystem. The Clinician Portal offers clinician-directed live sessions, homework assignments, and engagement analytics, while the Individual Program enables self-guided exposure therapy. Supporting the platform is an extensive VR Content Library of 1,000+ ultra HD 360-degree videos covering dozens of fear scenarios, sourced through both professional filming and Generative AI. Additional offerings include Bespoke VR Solutions for institutional clients, a Research Projects program for academic collaborations, Health Plans integration for insurance reimbursement, and oVRcome VR headset hardware. The platform is designed in compliance with RANZCP clinical guidelines and is used by over 1,800 organizations in 89 countries.
Differentiator
Problem solved
Functional benefit
Products and services
- oVRcome App
Quantifiable outcome
- 76% of people prefer VR over in vivo exposure for phobia treatment, with refusal rate for in vivo exposure 9 times higher than for VR exposure
- +4 more outcomes
Companies that use oVRcome
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
oVRcome technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
oVRcome partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- University of CanterburycoreIntegration of oVRcome VR technology into University of Canterbury mental health research initiatives. Partnership aims to explore innovative approaches to treating fears and phobias using VR exposure therapy with Meta Quest Pro, combined with physiological data capture using Samsung Galaxy wearables.
- University of CanterburycoreCollaboration on Generative AI pilot study for exposure therapy. The study was approved by the Human Research Ethics Committee and explored how AI-generated personalized exposure content compares to filmed VR content for treating specific phobias. Clinical oversight provided by University of Canterbury clinicians.
- University of OtagocoreResearch partnership for clinical trials on VR exposure therapy. The first clinical trial focused on five specific phobias (Ethics ref 21/STH/1), and a second clinical trial was launched focusing on Social Anxiety. Dr. Cameron Lacey from University of Otago serves as the research lead.
- APA LabscoreAPA Labs (a unit of APA Services, Inc., the companion professional association of the American Psychological Association) is working with oVRcome to demonstrate the integrity, security, and quality of oVRcome's Virtual Exposure Therapy platform. oVRcome is in the process of earning an APA Labs Digital Badge.
Scale indicators7 records
Recent moves5 records
Expansion highlights6 records
oVRcome competitors and assessment
Company assessmentEmerging players
- Tripp: Tripp delivers VR-based mindfulness and mental wellness experiences direct to consumers via standalone headsets, addressing anxiety and stress. It shares the consumer-facing VR-for-anxiety use case with oVRcome and represents an alternative engagement model in the same category.
- Big Health: Big Health produces digital therapeutics (Sleepio, Daylight) for insomnia and anxiety, distributed through employer and health plan channels. While not VR-based, it competes for the same clinician-prescribed anxiety treatment budgets and reimbursement pathways that oVRcome's Health Plans offering targets.
- Limbic: Limbic offers an AI-driven mental health support platform used by therapists and NHS services in the UK to triage and support anxiety treatment. While not VR-based, it competes for clinician mindshare and payer contracts in the same digital mental health workflows where oVRcome is positioned.
- SyncThink: SyncThink delivers VR-based objective assessment and training tools for brain performance and mental health, used by clinicians and sports organizations. While narrower in scope than oVRcome, it shares the same VR-for-clinical-evaluation DNA and is sold into overlapping clinical accounts.
Direct peers
- Psious (now part of Headspace Health): Psious was a pioneering VR exposure therapy platform for phobias and anxiety, directly comparable to oVRcome's core offering of clinician-directed VRET with smartphone and headset delivery. It was acquired by Headspace Health, making the combined entity both a direct competitor in VR exposure and the closest analog for where oVRcome could integrate its clinician experience into a broader mental health platform.
- XRHealth: XRHealth operates a clinician-facing VR therapy platform for physical, cognitive, and mental health conditions, with reimbursed telehealth distribution in the US. The business model, target user (clinicians + patients), and use of VR for therapeutic exposure and rehabilitation make it one of the closest direct competitors to oVRcome.
- MindMaze: MindMaze builds VR-driven neurorehabilitation and behavioral health platforms used by clinical providers, including tools for cognitive and emotional recovery. Its VR clinical platform and overlap with the mental health/neurotherapy market align it with oVRcome's product category.
- AppliedVR: AppliedVR is a digital therapeutic company that delivers VR-based treatment programs for chronic pain and behavioral health conditions through clinicians and home users. It is among the most clinically validated VR therapy companies with FDA authorization, directly comparable to oVRcome in the VR-as-therapeutic-modality category.
- BehaVR: BehaVR (which acquired assets from Oxford VR) develops immersive VR mental health programs for anxiety, depression, and chronic pain, delivered through clinicians and employer health plans. Its focus on evidence-based VR therapeutics in mental health overlaps directly with oVRcome's therapist-led VRET offering.
Broad incumbents
- Headspace Health: Headspace Health is a broad mental health platform combining the Headspace app with the Ginger therapy network and the Psious VR exposure therapy offering. It is the most direct incumbent showing the strategic path of acquiring a VRET capability and embedding it into a larger behavioral health portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
oVRcome social profiles
Digital presenceoVRcome compliance and trust
Trust signalCompliance5 records
oVRcome financial estimates
Financial estimateRevenue estimate
Valuation estimate
oVRcome leadership team
Management profileNumber of profiles
Profiles2 records
oVRcome funding detail
Funding detailFunding overview
Funding rounds7 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
oVRcome M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about oVRcome
What does oVRcome do?
oVRcome provides a virtual reality exposure therapy (VRET) platform that combines a smartphone-based VR app for individuals with a web-based Clinician Portal for licensed mental health professionals. The platform delivers clinician-directed and self-guided immersive 360° VR experiences for treating phobias, social anxiety, and related anxiety disorders, supported by a library of 1,000+ ultra HD 5.7K clips and AI-generated personalized exposure content.
Is oVRcome a public or private company?
oVRcome is a private company. It is classified as venture growth investor backed and is currently operating.
When was oVRcome founded?
oVRcome was founded in 2020. It employs 11 to 50 people.
Where is oVRcome based?
oVRcome is headquartered in Christchurch, New Zealand, in the Oceania region.
How does oVRcome make money?
Four revenue lines are on record. Individual Subscriptions are the primary driver. The others are clinician Portal Subscriptions, hardware Sales (VR Headsets) and gift Subscriptions.
Who are oVRcome's main competitors?
Emerging players on record are Tripp, Big Health, Limbic and SyncThink. Direct peers are Psious (now part of Headspace Health), XRHealth, MindMaze, AppliedVR and BehaVR. Headspace Health is listed as a broad incumbent.
Does oVRcome have an API?
No public API is recorded for oVRcome.
What industry is oVRcome in?
oVRcome's product category is Digital Mental Health / Virtual Reality Exposure Therapy. Its primary akta.pro industry code is MPAHACAN, Immersive/Interactive Animation (AR/VR/Real-Time), with a secondary code of EDAFAJAA, VR-Based Skills Training Simulations (Soft Skills, Customer Service, Leadership). Its NAICS code is 621112 and its SIC code is 7371.